Author Correction: Enoxaparin augments alpha-1-antitrypsin inhibition of TMPRSS2, a promising drug combination against COVID-19

• Xiyuan Bai,
• Ashley M. Buckle,
• Eszter K. Vladar,
• Edward N. Janoff,
• Reeti Khare,
• Diane Ordway,
• David Beckham,
• Lorelenn B. Fornis,
• Abraham Majluf-Cruz,
• Randolph V. Fugit,
• Brian M. Freed,
• Soohyun Kim,
• Robert A. Sandhaus,
• Edward D. Chan

Affiliations

Xiyuan Bai

Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center

Ashley M. Buckle

Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University

Eszter K. Vladar

Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Anschutz Medical Campus

Edward N. Janoff

Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center

Reeti Khare

Mycobacteriology Laboratory, Advance Diagnostics, National Jewish Health

Diane Ordway

Department of Microbiology, Immunlogy, and Pathology, Colorado State University

David Beckham

Division of Infectious Diseases, University of Colorado Anschutz Medical Campus

Lorelenn B. Fornis

Department of Academic Affairs and Medicine, National Jewish Health

Abraham Majluf-Cruz

Unidad de Investigacion Medica en Trombosis, Hemostasia y Aterogenesis, Instituto Mexicano del Seguro Social

Randolph V. Fugit

Department of Pharmacy, Rocky Mountain Regional Veterans Affairs Medical Center

Brian M. Freed

Department of Immunology, University of Colorado Anschutz Medical Campus

Soohyun Kim

Laboratory of Cytokine Immunology, Department of Biomedical Science and Technology, Konkuk University

Robert A. Sandhaus

Department of Academic Affairs and Medicine, National Jewish Health

Edward D. Chan

Department of Medicine, Rocky Mountain Regional Veterans Affairs Medical Center